Summary
Twenty cases of giant cell tumour of bone treated over an eleven year period were analysed. The minimum follow-up time was two years with an average of six years. Primary treatment consisted of a detailed curettage alone, without bone graft. A recurrence rate of 35% (7 patients) was recorded. Cases of recurrence were suitable for resection and endoprosthetic replacement. We conclude that detailed curettage alone, without bone graft, is an effective primary treatment for patients with giant cell tumour of bone.
Résumé
Analyse de 20 cas de tumeurs osseuses à cellules géantes traitées durant une période de onze ans. Le recul minimal est de 2 ans, avec une moyenne de 6 ans. Le traitement initial a consisté en un curettage soigneux simple, sans comblement par greffe osseuse. On a noté un taux de récidive de 35% (7 malades). Ces cas de récidive sont l'indication d'une résection avec remplacement prothétique. On peut conclure que le curettage simple, sans greffe associée, constitue un traitement primitif efficace pour les sujets atteints de tumeurs osseuses à cellules géantes.
Similar content being viewed by others
References
Cooper, Astley, Travers B (1818) Surgical essays, vol 1. Cox and Son and Longman and Co., London, pp 186–208
Dahlin DC, Cupps RE, Johnson EW (1970) Giant cell tumour: A study of 195 cases. Cancer 25:1061
Ellis F (1949) Treatment of osteoclastoma by radiation. J Bone Joint Surg 31:268
Enneking WF (1983) Musculoskeletal tumour surgery. Vol 1:87–88; vol. 2: 1439–1422. Churchill Livingstone, Edinburgh
Goldenberg RR, Campbell CJ, Bonfiglio M (1970) Giant cell tumour of bone. J Bone Joint Surg 52:619–663
Harris WR, Lehmann ECH (1983) Recurrent giant-cell tumour after en bloc excision of the distal radius and fibular autograft replacement. J Bone Joint Surg 65:618
Jaffe HL (1953) Giant-cell tumour (Osteoclastoma) of bone: Its pathological delineation and the inherent clinical implications. Ann R Coll Surg Engl 13:343
Jaffe HL, Lichtenstein L, Portis RB (1940) Giant-cell Tumour of bone. Its pathological appearance, grading, supposed variants and treatment. Arch Pathol 30:993
Johnson EW, Dahlin DC (1959) Treatment of giant-cell tumour of bone. J Bone Joint Surg 41:895
Marcove RC, Lyden JP, Huvos AG, Bullough PB (1973) Giant-cell tumours treated by Cryosurgery. J Bone Joint Surg 55:1633
Mnaymneh WA, Dudley HR, Mnaymneh LG (1964) Giant-cell tumour of bone. Analysis and follow-up of the forty-one cases observed at the Massachusetts General Hospital between 1925 and 1960. J Bone Joint Surg 46:63
McGrath PJ, Pymble (1972) Giant-cell tumours of bone. J Bone Joint Surg 54:216
Nascimento AG, Huvos AG, Margove RC (1979) Primary malignant giant cell tumour of bone. Cancer 44:1393
Persson BM, Ekellund L, Lövdahl R, Gunterber B (1984) Favourable results of acrylic cementation for giant cell tumours. Acta Orthop Scand 55:209–214
Pho RW (1981) Malignant giant-cell tumour of the distal end of the radius treated by a free vascularized fibular transplant. J Bone Joint Surg 63:877
Prossor TM (1949) Treatment of giant-cell tumours of bone. J Bone Joint Surg 31:241
Reckling FW, Gurtler RA, Mantz FA (1979) Recurrent giant-cell tumour of bone in a thirteen-year-old girl. J Bone Joint Surg 61:281
Sung HW, Kuo DP, Shu WP, Chai YB, Liu CC, Li SM (1982) Giant-cell tumour of bone: analysis of two hundred and eight cases in chinese patients. J Bone Joint Surg 64:755
Wearne WM (1968) Giant cell tumour of bone. J Bone Joint Surg 50:676
Windeyer BW, Woodyatt PB (1949) Osteoclastoma. A study of thirty-eight cases. J Bone Joint Surg 31:252
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waldram, M.A., Sneath, R.S. Is bone graft necessary?. International Orthopaedics 14, 129–133 (1990). https://doi.org/10.1007/BF00180116
Issue Date:
DOI: https://doi.org/10.1007/BF00180116